Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis

BACKGROUND: Several studies have demonstrated reduced serological response to vaccines in patients treated with anti-CD20 agents. However, limited data exist surrounding the clinical effect of disease modifying therapy (DMT) use on vaccine efficacy. OBJECTIVES: To investigate breakthrough coronaviru...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Deja R, Mahadeen, Ahmad Z, Carlson, Alise K, Planchon, Sarah M, Sedlak, Jennifer, Husak, Scott, Bermel, Robert A, Cohen, Jeffrey A, Moss, Brandon P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673876/
https://www.ncbi.nlm.nih.gov/pubmed/34925875
http://dx.doi.org/10.1177/20552173211057110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673876/
https://www.ncbi.nlm.nih.gov/pubmed/34925875
http://dx.doi.org/10.1177/20552173211057110

Ejemplares similares